首页> 外文期刊>PLOS Neglected Tropical Diseases >First Outbreak Response Using an Oral Cholera Vaccine in Africa: Vaccine Coverage, Acceptability and Surveillance of Adverse Events, Guinea, 2012
【24h】

First Outbreak Response Using an Oral Cholera Vaccine in Africa: Vaccine Coverage, Acceptability and Surveillance of Adverse Events, Guinea, 2012

机译:非洲首次使用口服霍乱疫苗应对疫情:不良事件的疫苗覆盖率,可接受性和监测,几内亚,2012年

获取原文
           

摘要

Background Despite World Health Organization (WHO) prequalification of two safe and effective oral cholera vaccines (OCV), concerns about the acceptability, potential diversion of resources, cost and feasibility of implementing timely campaigns has discouraged their use. In 2012, the Ministry of Health of Guinea, with the support of Médecins Sans Frontières organized the first mass vaccination campaign using a two-dose OCV (Shanchol) as an additional control measure to respond to the on-going nationwide epidemic. Overall, 316,250 vaccines were delivered. Here, we present the results of vaccination coverage, acceptability and surveillance of adverse events.
机译:背景技术尽管世界卫生组织(WHO)已对两种安全有效的口服霍乱疫苗(OCV)进行了资格预审,但人们对可接受性,潜在的资源转移,成本以及实施及时运动的可行性的担忧却阻碍了它们的使用。 2012年,几内亚卫生部在无国界医生的支持下组织了第一次大规模疫苗接种运动,使用两剂OCV(Shanchol)作为额外的控制措施,以应对持续的全国性流行病。总共交付了316,250种疫苗。在这里,我们介绍了疫苗接种覆盖率,可接受性和不良事件监测的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号